Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Beattie

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chemical Biology & Drug Design|July 28, 2012
Design, synthesis and fungicidal activity of novel sclerotiorin derivativesLong Lin, Nick Mulholland, Shao-Wei Huang, et al.
Journal of Agricultural and Food Chemistry|March 24, 2012
Synthesis and antifungal activity of novel sclerotiorin analoguesLong Lin, Nick Mulholland, Qiong-You Wu, et al.
European Journal of Medicinal Chemistry|December 10, 2016
Synthesis and antifungal activity of novel indole-replaced streptochlorin analoguesMing-Zhi Zhang, Chen-Yang Jia, Yu-Cheng Gu, et al.
Molecular Diversity|August 15, 2013
The discovery of 3-(1-aminoethylidene)quinoline-2, 4(1H,3H)-dione derivatives as novel PSII electron transport inhibitorsYu-Xiu Liu, Hua-Ping Zhao, Zi-Wen Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of beta2-adrenoceptor agonists as inhaled long-acting bronchodilatorsDavid Beattie, Michelle Bradley, Andrew Brearley, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Journal of Medicinal Chemistry|September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide coreTimothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonistsDavid Beattie, Andrew Brearley, Zarin Brown, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterolDavid Beattie, David Beer, Michelle E Bradley, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemical Biology & Drug Design|July 28, 2012
Design, synthesis and fungicidal activity of novel sclerotiorin derivativesLong Lin, Nick Mulholland, Shao-Wei Huang, et al.
Journal of Agricultural and Food Chemistry|March 24, 2012
Synthesis and antifungal activity of novel sclerotiorin analoguesLong Lin, Nick Mulholland, Qiong-You Wu, et al.
European Journal of Medicinal Chemistry|December 10, 2016
Synthesis and antifungal activity of novel indole-replaced streptochlorin analoguesMing-Zhi Zhang, Chen-Yang Jia, Yu-Cheng Gu, et al.
Molecular Diversity|August 15, 2013
The discovery of 3-(1-aminoethylidene)quinoline-2, 4(1H,3H)-dione derivatives as novel PSII electron transport inhibitorsYu-Xiu Liu, Hua-Ping Zhao, Zi-Wen Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2010
A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of beta2-adrenoceptor agonists as inhaled long-acting bronchodilatorsDavid Beattie, Michelle Bradley, Andrew Brearley, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Development of autotaxin inhibitors: A series of tetrazole cinnamidesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
Journal of Medicinal Chemistry|September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide coreTimothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonistsDavid Beattie, Andrew Brearley, Zarin Brown, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterolDavid Beattie, David Beer, Michelle E Bradley, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Pageof 3